Search Results - Olson, Walter

Review of "Cardiac Fibrillation-Defibrillation: Clinical and Engineering Aspects", by Max E. Valentinuzzi by Olson, Walter H

Get full text Get full text

Treatment of cystic ovaries by Lees, V. Wayne, Olson, Walter O.

Get full text Get full text

Antibody response to melanoma helper-peptide vaccine correlates with survival by Olson, Walter C, Reed, Caroline M, Slingluff, Craig L

Get full text Get full text

T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins by Salerno, Elise P, Olson, Walter C, McSkimming, Chantel, Shea, Sofia, Slingluff, Craig L

Get full text Get full text Get full text

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival by Reed, Caroline M., Cresce, Nicole D., Mauldin, Ileana S., Slingluff, Craig L., Olson, Walter C.

Get full text Get full text Get full text

TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10 by Mauldin, Ileana S., Wang, Ena, Deacon, Donna H., Olson, Walter C., Bao, Yongde, Slingluff, Craig L.

Get full text Get full text Get full text

Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2 by Molhoek, Kerrington R., McSkimming, Chantel C., Olson, Walter C., Brautigan, David L., Slingluff, Craig L.

Get full text Get full text Get full text

Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies by Shukla, Girja S., Olson, Walter C., Pero, Stephanie C., Sun, Yu-jing, Carman, Chelsea L., Slingluff, Craig L., Krag, David N.

Get full text Get full text Get full text

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine by Hu, Yinin, Petroni, Gina R., Olson, Walter C., Czarkowski, Andrea, Smolkin, Mark E., Grosh, William W., Chianese-Bullock, Kimberly A., Slingluff, Craig L.

Get full text Get full text Get full text

A Randomized Phase II Trial of Multi-epitope Vaccination with Melanoma Peptides for Cytotoxic T-Cells and Helper T-Cells for Patients with Metastatic Melanoma (E1602) by Slingluff, Craig L., Lee, Sandra, Zhao, Fengmin, Chianese-Bullock, Kimberly A., Olson, Walter, Butterfield, Lisa H., Whiteside, Theresa, Leming, Philip D., Kirkwood, John M.

Get full text Get full text Get full text

Immunologic hierarchy and promiscuity of melanoma helper peptides by Hu, Yinin, Petroni, Gina R, Olson, Walter C, Czarkowski, Andrea, Smolkin, Mark, Grosh, William W, Rehm, Patrice K, Murphy, Cheryl F, Coleman, Elizabeth J

Get full text Get full text

Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield,... by Olson, Walter C, Smolkin, Mark E, Farris, Erin M, Fink, Robyn J, Czarkowski, Andrea R, Fink, Jonathan H, Chianese-Bullock, Kimberly A, Slingluff, Craig L

Get full text Get full text Get full text

Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide by Salerno, Elise P., Shea, Sofia M., Olson, Walter C., Petroni, Gina R., Smolkin, Mark E., McSkimming, Chantel, Chianese-Bullock, Kimberly A., Slingluff, Craig L.

Get full text Get full text Get full text

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes by Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L

Get full text Get full text

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes by Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L

Get full text Get full text Get full text

A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes by Slingluff, Craig L, Petroni, Gina R, Olson, Walter C, Chianese-bullock, Kimberly A, Smith, Kelly T, Smolkin, Mark E, Galeassi, Nadedja, Grosh, William, Weiss, Geoffrey, Scott, Kristy, Hornillo, Ana

Get full text Get full text

Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma by Melssen, Marit M., Olson, Walter, Wages, Nolan A., Capaldo, Brian J., Mauldin, Ileana S., Mahmutovic, Adela, Hutchison, Ciara, Melief, Cornelis J.M., Bullock, Timothy N., Engelhard, Victor H., Slingluff, Craig L.

Get full text Get full text Get full text

EFFECT OF GM-CSF ON CIRCULATING CD8(+) AND CD4(+) T CELL RESPONSES TO A MULTIPEPTIDE MELANOMA VACCINE: OUTCOME OF A MULTICENTER RANDOMIZED TRIAL by Slingluff, Craig L., Petroni, Gina R., Olson, Walter C., Smolkin, Mark E., Ross, Merrick I., Haas, Naomi B., Grosh, William W., Boisvert, Marc E, Kirkwood, John M., Chianese-Bullock, Kimberly A.

Get full text Get full text Get full text

Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer by Knapp, Kiley A., Pires, Eusebio S., Adair, Sara J., Mandal, Arabinda, Mills, Anne M., Olson, Walter C., Slingluff, Craig L., Parsons, J. Thomas, Bauer, Todd W., Bullock, Timothy N., Herr, John C.

Get full text Get full text Get full text

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist by Meneveau, Max O, Petroni, Gina R, Salerno, Elise P, Lynch, Kevin T, Smolkin, Mark, Woodson, Elizabeth, Chianese-Bullock, Kimberly A, Olson, Walter C, Deacon, Donna, Patterson, James W, Grosh, William W, Slingluff, Craig L

Get full text Get full text Get full text